Lykan Bioscience names new CTO
Courtesy | Lykan Bioscience
Hopkinton life sciences manufacturer Lykan Bioscience has named Kenneth LeClair as its chief technology officer.
LeClair will be a member of the executive leadership team and will be responsible for leading the company's Manufacturing Science and Technology and Process Development teams, according to an April release from Lykan.
LeClair has more than 40 years of academic and industry experience. Prior to Lykan, LeClair was vice president of technical development and manufacturing at TScan Therapeutics in Waltham and Editas Medicine in Cambridge. Before that, he spent eight years at Swiss pharmaceutical company Novartis, transitioning biologic candidates from research into clinical development.
LeClair joins the team a little over a month after Patrick Lucy was named the organization’s CEO.
WBJ Web Partners
Most Recent
Most Recent
0 Comments